Edsmyr F, Esposti P L, Andersson L
Scand J Urol Nephrol Suppl. 1980;55:139-42.
Ninety patients with poorly differentiated prostatic carcinoma have been treated with Estramustine phosphate (Estracyt). Seventeen of them had clinically metastases and had had no previous therapy. Seventy-three were initially given oestrogens and/or irradiation. Objective response was observed in 59%. The best effect was seen in patients primarily untreated.
90例低分化前列腺癌患者接受了磷酸雌莫司汀(癌腺治)治疗。其中17例有临床转移且此前未接受过治疗。73例最初接受了雌激素和/或放疗。观察到客观缓解率为59%。最佳疗效见于初治患者。